Loading...

Oncolytic Immunotherapy | Cold Genesys | CG0070

2,823 views

Loading...

Loading...

Transcript

The interactive transcript could not be loaded.

Loading...

Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Uploaded on Dec 16, 2015

Cold Genesys is a clinical-stage immuno-oncology company focused on the development of oncolytic immunotherapies to combat cancer. The company’s lead candidate CG0070 has completed an investigation in a Phase 2, single-arm, open-label, multicenter study (BOND2) for patients with NMIBC who failed BCG therapy and refused cystectomy. In addition, Cold Genesys is exploring the use of CG0070 in combination with immune checkpoint modulators in different solid tumors.

For more information please visit our website:
http://www.coldgenesys.com



Production done by Alpha Tauri 3D
http://alphatauri3d.com

Loading...

to add this to Watch Later

Add to

Loading playlists...